Entero Healthcare Solutions accepts director resignation

Entero Healthcare Solutions has accepted the resignation of Mr. Kevin Rohitbhai Daftary as a Nominee Director on its Board, effective June 12, 2026. The resignation was submitted due to an increase in his professional responsibilities and commitments. Mr. Daftary represented the Prasid Uno Family Trust on the Board. The company confirmed that there are no other material reasons for the resignation beyond those disclosed.

The disclosure was made to the stock exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that the vacancy caused by the resignation will be filled in due course upon receipt of a fresh nomination from the Prasid Uno Family Trust.

Mr. Kevin Rohitbhai Daftary (DIN: 10637792) served as a Non-Executive Nominee Director. In his resignation letter, he confirmed that the specified reason was the sole material cause for stepping down. He requested the Board to record the resignation and submit the necessary intimations to the Stock Exchanges, the Registrar of Companies (ROC), and the Ministry of Corporate Affairs (MCA).

The following table details the regulatory disclosure regarding the change in directorship:

Sr. No.	Particulars	Details
1.	Reason for change	Resignation of Mr. Kevin Rohitbhai Daftary (DIN: 10637792), Nominee Director representing "Prasid Uno Family Trust", due to increase in professional responsibilities and commitments.
2.	Date of cessation	June 12, 2026
3.	Brief Profile	Not Applicable
4.	Disclosure of relationships

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.83%	-0.25%	-7.83%	+12.91%	-5.79%	-1.12%

Promoters of Entero Healthcare Solutions Limited , including Prem Sethi, Prabhat Agrawal, and OrbiMed Asia III Mauritius Limited, have declared that no encumbrance was created on the company's shares during the financial year ended March 31, 2026. The disclosures confirm that neither the promoters nor persons acting in concert with them established any direct or indirect charges on the shares throughout FY26.

The declarations were submitted to BSE Limited and the National Stock Exchange of India Limited in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation mandates annual disclosures by promoters to ensure transparency regarding any pledges or charges on their holdings.

Key Filing Details

Detail	Information
Promoter Name	Prem Sethi, Prabhat Agrawal, OrbiMed Asia III Mauritius Limited
Regulation	Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Financial Year	FY26 (ended March 31, 2026)
Encumbrance Status	No encumbrance created